Menghan Zhang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration.
Journal: Gut microbes
Published: June 27, 2025
A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
Journal: Frontiers in pharmacology
Published: December 23, 2023
The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC.
Journal: Cancer gene therapy
Published: December 06, 2023
Correction: Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.
Journal: BMC public health
Published: July 18, 2023
Spatial-Temporal Evolution and Improvement Measures of Embodied Carbon Emissions in Interprovincial Trade for Coal Energy Supply Bases: Case Study of Anhui, China.
Journal: International journal of environmental research and public health
Published: November 18, 2022
Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma.
Journal: Stem cell research & therapy
Published: July 25, 2022
FeOCl-confined activated carbon for improving intraparticle Fenton-like oxidation regeneration.
Journal: Journal of hazardous materials
Published: June 04, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026